本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aurinia Pharmaceuticals Inc

16.87
-0.0900-0.53%
成交量:20.01萬
成交額:338.15萬
市值:22.45億
市盈率:7.32
高:17.16
開:17.06
低:16.77
收:16.96
52周最高:19.25
52周最低:10.34
股本:1.33億
流通股本:1.29億
量比:0.81
換手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):2.30
每股收益(LYR):2.07
淨資產收益率:66.12%
總資產收益率:15.49%
市淨率:3.65
市盈率(LYR):8.15

資料載入中...

2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/08/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

超過5%披露

[Amend] General statement of acquisition of beneficial ownership